Axinn partner Chad Landmon was profiled in the Connecticut Law Tribune article, “Generic Drug Litigation: A Growing Practice Niche.”

Published on November 19, 2012, the article highlights how “Hartford’s Axinn, Veltrop & Harkrider, specifically partner Chad Landmon, recently notched a big victory over the FDA on behalf of the maker of a generic diabetes drug.” The piece goes on to describe the growing FDA practice area, specifically as it relates to generic drug manufacturers.

Click here to access the article.